The company is a national key Chinese patent medicine R&D and production base, and has built 14 dosage forms 16 high-standard production lines, forming a series of products mainly including Zhenshiming, Xiatianwu, Kang Xue and Changyanning, covering medicinal tablets, capsules, granules, syrups, oral liquids, small-volume injections, dripping pills, oral liquids and eye drops (including. The dominant product pattern of 32 1 variety (specification), including 20 new drug varieties, 25 national protection products and 4 national exclusive production varieties/kloc-0.
As one of the four key pilot units to establish a modern enterprise system in China and one of the provincial high-tech enterprises, the company has vigorously promoted scientific and technological innovation, established a standardized corporate governance structure, consolidated the internal basic management of enterprises, and steadily improved its economic benefits. The company has successively undertaken the national demonstration project of modernization and industrialization of traditional Chinese medicine and the Tenth Five-Year Scientific and Technological Project, and all six leading products (Zhenshiming Eye Drops, Xiatianwu Tablets, Compound Xiatianwu Tablets, Xiatianwu Needles, Changyanning Film-coated Tablets and Triamcinolone acetonide Nasal Spray) have obtained high-tech product demonstration certificates.